Diverticular disease

Czech version

Authors: J. Špičák; G. Suchánková; M. Kučera
Authors‘ workplace: Klinika hepatogastroenterologie, IKEM, Praha
Published in: Gastroent Hepatol 2014; 68(4): 307-318
Category: Clinical and Experimental Gastroenterology: Review Article

Overview

Diverticular disease has a high prevalence percentage and an increasing incidence, even in young individuals. Its incidence is usually associated with relatively low-fibre diet. Other risk factors include smoking, opiate or corticoid consumption, obesity, alcoholism and smoking and non-steroid antiphlogistics. Patients with diverticular disease also display abnormal intestinal motility, intestinal dysbiosis and other physiological and morphological abnormalities. Most diverticuloses occur in the sigmoid colon, however, occurrence in the colon ascendens is increasing, especially in Asia. There are also several classification schemes, among which individual assessment of complications is becoming the most important. The incidence of diverticulosis used to be over 10% of all the diverticuloses, but nowadays it is lower. The diagnosis includes clinical testing, general laboratory tests of the inflammation, coloscopy, ultrasound, CT and magnetic resonance. The treatment of symptomatic uncomplicated diverticulosis is based on medicines bringing symptomatic relief, fibre, mesalazine, probiotics and non-absorbed antibiotics. Diverticular disease with a mild progression can be treated only by hydration and modification of the dietary regimen. In the case of complications and sepsis, antibiotics are administered. By way of prevention of further attacks, again probiotics, mesalazine and non-absorbed antibiotics are administered, these at one-month intervals. The ratio of operated patients is decreasing even in the case of acute states, and the efficiency of the conservative treatment of diverticulosis is above 80%. The abscess should be primarily treated by non-surgical drainage. Even peritonitis can be treated by means of laparoscopic drainage without the necessity of subsequent operation. In the past, elective resection was recommended after two attacks of diverticulitis, but today emphasis is laid on an individual approach considering age, comorbidities and the character of the disease. The percentage of laparoscopic resections is increasing. The results for the Hartmann's operation and the primary resection are almost identical.

Key words:
diverticular disease – probiotics – mesalazine – resection

The authors declare they have no potential conflicts of interest concerning drugs, products, or services used in the study.

The Editorial Board declares that the manuscript met the ICMJE „uniform requirements“ for biomedical papers.

Submitted:
21. 4. 2014

Accepted:
26. 5. 2014

Sources

1. Shaheen NJ, Hansen RA, Morgan DR et al. The burden of gastrointestinal and liver diseases, 2006. Am J Gastroenterol 2006; 101(9): 2128–2138.

2. Etzioni DA, Mack TM, Beart RW Jr et al. Diverticulitis in the United States: 1998–2005: changing patterns of disease and treatment. Ann Surg 2009; 249(2): 210–217. doi: 10.1097/SLA.0b013e3181952888.

3. Warner E, Crighton EJ, Moineddin R et al. Fourteen-year study of hospital admissions for diverticular disease in Ontario. Can J Gastroenterol 2007; 21(2): 97–99.

4. Kang JY, Hoare J, Tinto A et al. Diverticular disease of the colon – on the rise: a study of hospital admissions in England between 1989/1990 and 1999/2000. Aliment Pharmacol Ther 2003; 17(9): 1189–1195.

5. Painter NS, Burkitt DP. Diverticular dis-ease of the colon: a deficiency disease of Western civilization. Br Med J 1971; 2(5759): 450–454.

6. Burkitt DP, Walker AR, Painter NS. Effect of dietary fibre on stools and the transit-times, and its role in the causation of dis-ease. Lancet 1972; 2(7792): 1408–1412.

7. Arora G, Mannalithara A, Mithal A et al. Concurrent conditions in patients with chronic constipation: a population-based study. PLoS One 2012; 7(10): e42910. doi: 10.1371/journal.pone.0042910.

8. Kang JY, Firwana B, Green AE et al. Uncomplicated diverticular disease is not a common cause of colonic symptoms. Aliment Pharmacol Ther 2011; 33(4): 487–494. doi: 10.1111/j.1365-2036.2010.04540.x.

9. Peery AF, Barrett PR, Park D et al. A high-fiber diet does not protect against asymptomatic diverticulosis. Gastroenterology 2012; 142(2): 266–272. doi: 10.1053/j.gastro.2011.10.035.

10. Strate LL, Liu YL, Syngal S et al. Nut, corn, and popcorn consumption and the incidence of diverticular disease. JAMA 2008; 300(8): 907–914. doi: 10.1001/jama.300.8.907.

11. Crowe FL, Balkwill A, Cairns BJ et al. Source of dietary fibre and diverticular disease incidence: a prospective study of UK women. Gut 2014. [In press]. doi: 10.1136/gutjnl-2013-304644.

12. Hjern F, Wolk A, Hakansson N. Smoking and the risk of diverticular disease in women. Br J Surg 2011; 98(7): 997–1002. doi: 10.1002/bjs.7477.

13. Humes DJ, Fleming KM, Spiller RC et al. Concurrent drug use and the risk of perforated colonic diverticular disease: a population-based case-control study. Gut 2011; 60(2): 219–224. doi: 10.1136/gut.2010.217281.

14. Strate LL, Liu YL, Huang ES et al. Use of aspirin or nonsteroidal anti-inflammatory drugs increases risk for diverticulitis and diverticular bleeding. Gastroenterology 2011; 140(5): 1427–1433. doi: 10.1053/j.gastro.2011.02.004.

15. Morris CR, Harvey IM, Stebbings WS et al. Do calcium channel blockers and antimuscarinics protect against perforated colonic diverticular disease? A case control study. Gut 2003; 52(12): 1734–1737.

16. Hjern F, Wolk A, Hakansson N. Obesity, physical inactivity, and colonic diverticular disease requiring hospitalization in women: a prospective cohort study. Am J Gastroenterol 2012; 107(2): 296–302. doi: 10.1038/ajg.2011.352.

17. Tonnesen H, Engholm G, Moller H. Association between alcoholism and diverticulitis. Br J Surg 1999; 86(8): 1067–1068.

18. Bassotti G, Sietchiping-Nzepa F, De Roberto G et al. Colonic regular contractile frequency patterns in irritable bowel syndrome: the 'spastic colon' revisited. Eur J Gastroenterol Hepatol 2004; 16(6): 613–617.

19. Golder M, Burleigh DE, Belai A et al. Smooth muscle cholinergic denervation hypersensitivity in diverticular disease. Lancet 2003; 361(9373): 1945–1951.

20. Böttner M, Barrenschee M, Hellwig I et al. The enteric serotonergic system is altered in patients with diverticular disease. Gut 2013; 62(12): 1753–1762. doi: 10.1136/gutjnl-2012-302660.

21. Bassotti G, Battaglia E, Bellone G et al. Interstitial cells of Cajal, enteric nerves, and glial cells in colonic diverticular disease. J Clin Pathol 2005; 58(9): 973–977.

22. Milner P, Crowe R, Kamm MA et al. Vasoactive intestinal polypeptide levels in sigmoid colon in idiopathic constipation and diverticular disease. Gastroenterology 1990; 99(3): 666–675.

23. Tursi A, Brandimarte G, Giorgetti GM et al. Assessment of small intestinal bacterial overgrowth in uncomplicated acute diverticulitis of the colon. World J Gastroenterol 2005; 11(18): 2773–2776.

24. Horgan AF, McConnell EJ, Wolff BG et al. Atypical diverticular disease: surgical results. Dis Colon Rectum 2001; 44(9): 1315–1318.

25. Parks TG. Natural history of diverticular disease of the colon. Clin Gastroenterol 1975; 4(1): 53–69.

26. Painter NS, Truelove SC, Ardran GM et al. Segmentation and the localization of intraluminal pressure in the human colon, with special reference to the pathogenesis of colonic diverticula. Gastroenterology 1968; 54 (4 Suppl): 778–780.

27. Sugihara K, Muto T, Morioka Y et al. Diverticular disease of the colon in Japan. A review of 615 cases. Dis Colon Rectum 1984; 27(8): 531–537.

28. Lohsiriwat V, Suthikeeree W. Pattern and distribution of colonic diverticulosis: analysis of 2877 barium enemas in Thailand. World J Gastroenterol 2013; 19(46): 8709–8713. doi: 10.3748/wjg.v19.i46.8709.

29. Shahedi KF, Fuller G, Bolus R et al. Progression from incidental diverticulosis to acute diverticulitis. Gastroenterology 2012; 142 (Suppl 1): 144.

30. Stollman N, Raskin JB. Diverticular dis-ease of the colon. Lancet 2004; 363(9409): 631–639.

31. Hart AR, Kennedy HJ, Stebbings WS et al. How frequently do large bowel diverticula perforate? An incidence and cross-sectional study. Eur J Gastroenterol Hepatol 2000; 12(6): 661–665.

32. Kvasnovsky CL, Papagrigoriadis S, Bjarnason I. Increased diverticular complications with nonsteroidal anti-inflammatory drugs and other medications: a systematic review and meta-analysis. Colorectal Dis 2014; 16(6): 189–196. doi: 10.1111/codi.12516.

33. Yap FY, Omene BO, Patel MN et al. Transcatheter embolotherapy for gastrointestinal bleeding: a single center review of safety, efficacy, and clinical outcomes. Dig Dis Sci 2013; 58(7): 1976–1984. doi: 10.1007/s10620-012-2547-z.

34. Couto-Worner I, González-Conde B, Estévez-Prieto E et al. Colonic diverticular bleeding: urgent colonoscopy without purging and endoscopic treatment with epinephrine and hemoclips. Rev Esp Enferm Dig 2013; 105(8): 495–498.

35. Ghassemi KA, Jensen DM. Lower GI bleeding: epidemiology and management. Curr Gastroenterol Rep 2013; 15(7): 333. doi: 10.1007/s11894-013-0333-5.

36. Hinchey EJ, Schaal PG, Richards GK. Treatment of perforated diverticular disease of the colon. Adv Surg 1978; 12: 85–109.

37. Hansen O, Stock W. Prophylactische operation bei der divertikelkrankheit des kolons – stufenkoncept durch exakte stadienteilung. Langenbecks Arch Chir 1999; Suppl II: 1257–1260.

38. Klarenbeek BR, de Korte N, van der Peet DL et al. Rerview of current classifications for diverticular disease and a translation into clinical practice. Int J Colorectal Dis 2012; 27(2): 207–214. doi: 10.1007/s00384-011-1314-5.

39. Lamps LW, Knapple WL. Diverticular disease-associated segmental colitis. Clin Gastroenterol Hepatol 2007; 5(1): 27–31.

40. Mulhall AM, Mahid SS, Petras RE et al. Diverticular disease associated with inflammatory bowel disease-like colitis: a systematic review. Dis Colon Rectum 2009; 52(6): 1072–1079. doi: 10.1007/DCR.0b013e31819ef79a.

41. Clemens CH, Samsom M, Roelofs J et al. Colorectal visceral perception in diverticular disease. Gut 2004; 53(5): 717–722.

42. Jung HK,Choung RS, Locke GR 3rd et al. Diarrhea-predominant irritable bowel syndrome is associated with diverticular disease: a population-based study. Am J Gastroenterol 2010; 105(3): 652–661. doi: 10.1038/ajg.2009.621.

43. Stallinger S, Eller N, Högenauer C. Non-interventional study evaluating efficacy and tolerability of rifaximin for treatment of uncomplicated diverticular disease. Wien Klin Wochenschr 2014; 126(1–2): 9–14. doi: 10.1007/s00508-013-0447-7.

44. Horgan AF, McConnell EJ, Wolff BG et al. Atypical diverticular disease: surgical results. Dis Colon Rectum 2001; 44(9): 1315–1318.

45. Green BT, Rockey DC, Portwood G et al. Urgent colonoscopy for evaluation and management of acute lower gastrointestinal hemorrhage: a randomized controlled trial. Am J Gastroenterol 2005; 100(11): 2395–2402.

46. Laméris W, van Randen A, Bipat S et al. Graded compression ultrasonography and computed tomography in acute colonic diverticulitis: meta-analysis of test accuracy. Eur Radiol 2008; 18(11): 2498–2511. doi: 10.1007/s00330-008-1018-6.

47. Heverhagen JT, Sitter H, Zielke A et al. Prospective evaluation of the value of magnetic resonance imaging in suspected acute sigmoid diverticulitis. Dis Colon Rectum 2008; 51(12): 1810–1515. doi: 10.1007/s10350-008-9330-4.

48. Sakhnini E, Lahat A, Melzer E et al. Early colonoscopy in patients with acute diverticulitis: results of a prospective pilot study. Endoscopy 2004; 36(6): 504–507.

49. Melchior S, Cudovic D, Jones J et al. Diagnosis and surgical management of colovesical fistulas due to sigmoid diverticulitis. J Urol 2009; 182(3): 978–982. doi: 10.1016/j.juro.2009.05.022.

50. Taylor I, Duthie HL. Bran tablets and diverticular disease. Br Med J 1976; 1(6016): 988–990.

51. Brodribb AJ. Treatment of symptomatic diverticular disease with a high-fibre diet. Lancet 1977; 1(8013): 664–666.

52. Hodgson WJ. The placebo effect. Is it important in diverticular disease? Am J Gastroeterol 1977; 67(2): 157–162.

53. Ornstein MH, Littlewood ER, Baird IM et al. Are fibre supplements really necessary in diverticular disease of the colon? A controlled clinical trial. Br Med J (Clin Res Ed) 1981; 282(6273): 1353–1356.

54. Smits BJ, Whitehead AM, Prescott P. Lactulose in the treament of symptomatic diverticular disease: a comparative study with high-fibre diet. Br J Clin Pract 1990; 44(8): 314–318.

55. Aldoori WH, Giovannucci EL, Rimm EB et al. A prospective study of diet and the risk of symptomatic diverticular disease in men. Am J Clin Nutr 1994; 60(5): 757–764.

56. Ünlü C, Daniels L, Vrouenraets BC et al. A systematic review of high-fibre dietary therapy in diverticular disease. Int J Colorectal Dis 2012; 27(4): 419–427. doi: 10.1007/s00384-011-1308-3.

57. Tursi A. Diverticular disease: a therapeutic overview. World J Gastrointest Pharmacol Ther 2010; 1(1): 27–35. doi: 10.4292/wjgpt.v1.i1.27.

58. Adamová Z. Divertikulární nemoc tračníku. Rozhl Chir 2011; 90: 463–477.

59. Antoš F. Divertikulární choroba tlustého střeva. Praha: Avicenum 1990: 141–149.

60. Chabok A, Pahlman L, Hjern F et al. Randomized clinical trial of antibiotics in acute uncomplicated diverticulitis. Br J Surg 2012; 99(4): 532–539. doi: 10.1002/bjs.8688.

61. Unlü C, de Korte N, Daniels L et al. A multicenter randomized clinical trial investigating the cost-effectiveness of treatment strategies with or without antibiotics for uncomplicated acute diverticulitis (DIABOLO trial). BMC Surg 2010; 10: 23. doi: 10.1186/1471-2482-10-23.

62. Papi C, Ciaco A, Koch M et al. Efficacy of rifaximin on symptoms of uncomplicated diverticular disease of the colon. A pilot multicentre open trial. Ital J Gastroenterol 1992; 24(8): 452–456.

63. Papi C, Ciaco A, Koch M et al. Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre double-blind placebo-controlled trial. Aliment Pharmacol Ther 1995; 9(1): 33–39.

64. Latella G, Pimpo MT, Sottili S et al. Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon. Int J Colorectal Dis 2003; 18(1): 55–62.

65. Pistoia MA, Lombardi L, Rossi M et al. Does rifaximin prevent complications of diverticular disease? A retrospective study. Eur Rev Med Pharmacol Sci 2004; 8(6): 283–287.

66. Colecchia A, Vestito A, Pasqui F et al. Efficacy of long term cyclic administration of the poorly absorbed antibiotic rifaximin in symptomatic, uncomplicated colonic diverticular disease. World J Gastroenterol 2007; 13(2): 264–269.

67. D´Inca R, Pomerri F, Vettorato MG et al. Interaction between rifaximin and dietary fibre in patients with diverticular disease. Aliment Pharmacol Ther 2007; 25(7): 771–779.

68. Trivedi CD, Das KM. Emerging therapies for diverticular disease of the colon. J Clin Gastroenterol 2008; 42(10): 1145–1151. doi: 10.1097/MCG.0b013e318188adc1.

69. Bianchi M, Festa V, Moretti A et al. Meta-analysis: long-term therapy with rifaximin in the management of uncomplicated diverticular disease. Aliment Pharmacol Ther 2011; 33(8): 902–910. doi: 10.1111/j.1365-2036.2011.04606.x.

70. Calanni F, Renzulli C, Fogli MV et al. Comment on: rifaximin in the treatment of irrit-able bowel syndrome. Is there a high risk for development of antimicrobial resistance? J Clin Gastroenterol 2013; 47(9): 814. doi: 10.1097/MCG.0b013e3182951b6c.

71. Trepsi E, Colla C, Panizza P et al. Therapeutic and prophylactic role of mesalazine (5-ASA) in symptomatic diverticular dis-ease of the large intestine. 4 year follow-up results. Minerva Gastroenterol Dietol 1999; 45(4): 245–252.

72. Tursi A, Brandimarte G, Daffina R. Long-term treatment with mesalazine and rifaximin versus rifaximin alone for patients with reccurent attacks of acute diverticulitis of colon. Dig Liver Dis 2002; 34(7): 510–515.

73. Tursi A, Brandimarte G, Giorgetti GM et al. Balsalazide and/or high-potency probiotic mixture (VSL#3) in maintaining remission after attack of acute, uncomplicated diverticulitis of the colon. Int J Colorectal Dis 2007; 22(9): 1103–1108.

74. Stollman N, Magowan S, Shanahan F et al. A randomized controlled study of mesalamine after acute diverticulitis: results of the DIVA trial. J Clin Gastroenterol 2013; 47(7): 621–629. doi: 10.1097/MCG.0b013e31828003f6.

75. Gatta L, Vakil N, Vaira D et al. Efficacy of 5-ASA in the treatment of colonic diverticular disease. J Clin Gastroenterol 2010; 44(2): 113–119. doi: 10.1097/MCG.0b013e3181a15864.

76. Shire. Shire announces top-line results of the PREVENT2 trial. [online]. Available from: http://www.shire.com/shireplc/en/investors/irshirenews?id=583.

77. Di Mario F, Aragona G, Leandro G et al. Efficacy of mesalazine in the treatment of symptomatic divesticular disease. Dig Dis Sci 2005; 50(3): 581–586.

78. Seth A, Yan F, Polk DB et al. Probiotics ameliorate the hydrogen peroxide-induced epithelial barrier disruption by a PKC- and MAP kinase-dependent mechanism. Am J Physiol Gastrointest Liver Physiol 2008; 294(4): G1060–G1069. doi: 10.1152/ajpgi.00202.2007.

79. Yan F, Cao H, Cover TL et al. Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 2007; 132(2): 562–575.

80. Borruel N, Carol M, Casellas F et al. Increased mucosal tumour necrosis factor alpha production in Crohn's disease can be downregulated ex vivo by probiotic bacteria. Gut 2002; 51(5): 659–664.

81. Lin YP, Thibodeaux CH, Peña JA et al. Probiotic Lactobacillus reuteri suppress proinflammatory cytokines via c-Jun. In-flamm Bowel Dis 2008; 14(8): 1068–1083. doi: 10.1002/ibd.20448.

82. Dalmasso G, Cottrez F, Imbert V et al. Saccharomyces boulardii inhibits inflammatory bowel disease by trapping T cells in mesenteric lymph nodes. Gastroenterology 2006; 131(6): 1812–1825.

83. Rousseaux C, Thuru X, Gelot A et al. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat Med 2007; 13(1): 35–37.

84. Tursi A, Brandimarte G, Giorgetti GM et al. Mesalazine and/or Lactobacillus casei in preventing recurrence of symptomatic uncomplicated diverticular disease of the colon: a prospective, randomized, open-label study. J Clin Gastroenterol 2006; 40(4): 312–316.

85. Annibale B, Maconi G, Lahner E et al. Efficacy of Lactobacillus paracasei sub. paracasei F19 on abdominal symptoms in patients with symptomatic uncomplicated diverticular disease: a pilot study. Minerva Gastroenterol Dietol 2011; 57(1): 13–22.

86. Lamiki P, Tsuchiya J, Pathak S et al. Probiotics in diverticular disease of the colon: an open label study. J Gastrointestin Liver Dis 2010; 19(1): 31–36.

87. Tursi A, Brandimarte G, Elisei W. Randomised clinical trial: mesalazine and//or probiotics in maintaining remission of symptomatic uncomplicated diverticular disease – a double-blind, randomised, placebo-controlled study. Aliment Pharmacol Ther 2013; 38(7): 741–751. doi: 10.1111/apt.12463.

88. Fric P, Zavoral M. The effect of non-pathogenic Escherichia coli in symptomatic uncomplicated diverticular disease of the colon. Eur J Gastroenterol Hepatol 2003; 15(3): 313–315.

89. Yan F, Polk DB. Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. J Biol Chem 2002; 277(52): 50959–50965.

90. Rachmilewitz D, Katakura K, Karmeli F et al. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 2004; 126(2): 520–528.

91. Katakura K, Lee J, Rachmilewitz D et al. Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. J Clin Invest 2005; 115(3): 695–702.

92. Yan F, Cao H, Cover TL et al. Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 2007; 132(2): 562–575.

93. Maconi G, Barbara G, Bosetti C et al. Treatment of diverticular disease of the colon and prevention of acute diverticulitis: a systematic review. Dis Colon Rectum 2011; 54(10): 1326–1338. doi: 10.1097/DCR.0b013e318223cb2b.

94. Chappuis CW, Cohn I Jr. Acute colonic diverticulitis. Surg Clin North Am 1988; 68: 301.

95. Biondo S, Parés D, Martí Ragué J et al. Acute colonic diverticulitis in patients under 50 years of age. Br J Surg 2002; 89(9): 1137–1141.

96. Schauer PR, Ramos R, Ghiatas AA et al. Virulent diverticular disease in young obese men. Am J Surg 1992; 164(5): 443–446.

97. Chodak GW, Rangel DM, Passaro E Jr. Colonic diverticulitis in patients under age 40: need for earlier diagnosis. Am J Surg 1981; 141(6): 699–702.

98. Fischer MG, Farkas AM. Diverticulitis of the cecum and ascending colon. Dis Colon Rectum 1984; 27(7): 454–458.

99. Markham NI, Li AK. Diverticulitis of the right colon – experience from Hong Kong. Gut 1992; 33(4): 547–549.

100. Lo CY, Chu KW. Acute diverticulitis of the right colon. Am J Surg 1996; 171(2): 244–246.

101. Ambrosetti P, Chautems R, Soravia C et al. Long-term outcome of mesocolic and pelvic diverticular abscesses of the left colon: a prospective study of 73 cases. Dis Colon Rectum 2005; 48(4): 787–791.

102. Siewert B, Tye G, Kruskal J et al. Impact of CT-guided drainage in the treatment of diverticular abscesses: size matters. Am J Roentgenol 2006; 186(3): 680–686.

103. Durmishi Y, Gervaz P, Brandt D et al. Results from percutaneous drainage of Hinchey stage II diverticulitis guided by computer tomography scan. Surg Endosc 2006; 20(7): 1129–1133.

104. Kumar RR, Kim JT, Haukoos JS et al. Factors affecting the successful management of intra-abdominal abscesses with antibiotics and the need for percutaneous drainage. Dis Colon Rectum 2006; 49(2): 183–189.

105. Kronborg O. Treatment of perforated sigmoid diverticulitis: a prospective randomized trial. Br J Surg 1993; 80(4): 505–507.

106. Zeitoun G, Laurent A, Rouffet F et al. Multicentre, randomized clinical trial of primary versus secondary sigmoid resection in generalized peritonitis complicating sigmoid diverticulitis. Br J Surg 2000; 87(10): 1366–1374.

107. Salem L, Flum DR. Primary anastomosis or Hartmann´s procedure for patients with diverticular peritonitis? A systematic review. Dis Colon Rectum 2004; 47(11): 1953–1964.

108. Constantinides VA, Tekkis PP, Athanasiou T et al. Primary resection with anastomosis vs. Hartmann's procedure in nonelective surgery for acute colonic diverticulitis: a systematic review. Dis Colon Rectum 2006; 49(7): 966–981.

109. Karoui M, Champault A, Pautrat K et al. Laparoscopic peritoneal lavage or primary anastomosis with defunctioning stoma for Hinchey 3 complicated diverticulitis: results of a comparative study. Dis Colon Rectum 2009; 52(4): 609–615. doi: 10.1007/DCR.0b013e3181a0a674.

110. Myers E, Hurley M, O´Sullivan GC et al. Laparoscopic peritoneal lavage for generalized peritonitis due to perforated divertikulitis. Br J Surg 2008; 95(1): 97–101.

111. Swank HA, Vermeulen J, Lange JF et al. The ladies trial: laparoscopic peritoneal lavage or resection for purulent peritonitis and Hartmann´s procedure or resection with primary anastomosis for purulent or faecal peritonitis in perforated divertikulitis (NTR2037). BMC Surg 2010; 10: 29. doi: 10.1186/1471-2482-10-29.

112. Somasekar K, Foster ME, Haray PN. The natural history diverticular disease: is there a role for elective colectomy? J R Coll Surg Edinb 2002; 47(2): 481–482, 484.

113. Broderick-Villa G, Burchette RJ, Collins JC et al. Hospitalization for acute diverticulitis does not mandate routine elective colectomy. Arch Surg 2005; 140(6): 576–581, discussion: 581–583.

114. Anaya DA, Flum DR. Risk of emergency colectomy and colostomy in patients with diverticular disease. Arch Surg 2005; 140(7): 681–685.

115. Ricciardi R, Baxter NN, Read TE et al. Is the decline in the surgical treatment for diverticulitis associated with an increase in complicated diverticulitis? Dis Colon Rectum 2009; 52(9): 1558–1563. doi: 10.1007/DCR.0b013e3181a90a5b.

116. Hjern F, Josephson T, Altman D et al. Outcome of younger patients with acute diverticulitis. Br J Surg 2008; 95(6): 758–764. doi: 10.1002/bjs.6137.

117. Klarenbeek BR, Bergamaschi R, Veenhof AA et al. Laparoscopic versus open sigmoid resection for diverticular disease: follow-up assessment of the randomized control Sigma trial. Surg Endosc 2011; 25(4): 1121–1126. doi: 10.1007/s00464-010-1327-0.

118. Klarenbeek BR, Coupé VM, van der Peet DL et al. The cost effectiveness of elective laparoscopic sigmoid resection for symptomatic diverticular disease: financial outcome of the randomized control Sigma trial. Surg Endosc 2011; 25(3): 776–783. doi: 10.1007/s00464-010-1252-2.

119. Gervaz P, Inan I, Perneger T et al. A prospective, randomized, single-blind comparison of laparoscopic versus open sigmoid colectomy for diverticulitis. Ann Surg 2010; 252(1): 3–8. doi: 10.1097/SLA.0b013e3181dbb5a5.

120. Purkayastha S, Constantinides VA, Tekkis PP et al. Laparoscopic vs. open surgery for diverticular disease: a meta-analysis of nonrandomized studies. Dis Colon Rectum 2006; 49(4): 446–463.

121. Jones OM, Stevenson AR, Clark D et al. Laparoscopic resection for diverticular dis-ease: follow-up of 500 consecutive patients. Ann Surg 2008; 248(6): 1092–1097. doi: 10.1097/SLA.0b013e3181884923.

122. Reissfelder C, Buhr HJ, Ritz JP. What is the optimal time of surgical intervention after an acute attack of sigmoid diverticulitis: early or late elective laparoscopic resection? Dis Colon Rectum 2006; 49(12): 1842–1848.

123. Thaler K, Baig MK, Berho M et al. Determinants of recurrence after sigmoid resection for uncomplicated diverticulitis. Dis Colon Rectum 2003; 46(3): 385–388.